ICCC vs SNY
ImmuCell Corporation (ICCC) versus SNY (SNY) — a side-by-side from cached financials, not a winner call.
ImmuCell Corporation (ICCC) is a biotechnology company listed on US.
SNY (SNY) common stock.
Latest reported ICCC revenue for 2026-06-30 was $17.5M. Net income was $3.8M. Revenue was up 69.4% from 2026-03-31 to 2026-06-30. ICCC currently screens at market cap $58.9M.
SNY does not have a complete income-statement cache yet.
ICCC currently screens at market cap $58.9M. SNY currently screens at market cap $0.
Not investment advice. Open the ICCC and SNY stock pages for the full models.
Not investment advice.